Compagnie Lombard Odier SCmA’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,584	Closed	-$4K	–	897
2016 Q3	$4K	Hold	7,584	–	–	﹤0.01%	879
2016 Q2	$4K	Hold	7,584	–	–	﹤0.01%	870
2016 Q1	$11K	Sell	7,584 -245	-3%	-$483	﹤0.01%	883
2015 Q4	$25K	Hold	7,829	–	–	﹤0.01%	777
2015 Q3	$50K	Buy	7,829 +2,600	+50%	+$24.3K	﹤0.01%	607
2015 Q2	$51K	Hold	5,229	–	–	﹤0.01%	642
2015 Q1	$40K	Hold	5,229	–	–	﹤0.01%	804
2014 Q4	$28K	Hold	5,229	–	–	﹤0.01%	674
2014 Q3	$26K	Hold	5,229	–	–	﹤0.01%	775
2014 Q2	$35K	Hold	5,229	–	–	﹤0.01%	778
2014 Q1	$39K	Buy	5,229 +4,400	+531%	+$26.1K	﹤0.01%	748
2013 Q4	$3K	Buy	+829	New	+$3.21K	﹤0.01%	841

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MBT

Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NWBO Position: Q4 2016 in Review

Compagnie Lombard Odier SCmA sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 7,584 shares — an estimated $4K sold.

Compagnie Lombard Odier SCmA first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $51K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

Compagnie Lombard Odier SCmA reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 7,584 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $4K.
Compagnie Lombard Odier SCmA first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 12 quarters.
Compagnie Lombard Odier SCmA's Northwest Biotherapeutics, Inc. Common stock position peaked at $51K in Q2 2015.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.